Tanzania Radiotherapy Market Report 2022 to 2030

Tanzania Radiotherapy Market Analysis

$ 3999

The Radiotherapy Therapeutics Market in Tanzania is dominated by a few domestic players such as Ocean Road Cancer Institute, Varian Medical Systems, and Siemens. The radiotherapy market in Tanzania is segmented into different types, technology, procedures, applications, and end-users. The significant risk factors associated with awareness of radiotherapy shortage of skilled staff, government initiatives, and reimbursement policy. The demand for Tanzania Radiotherapy is increasing due to the rise in cancer cases in the country.

ID: IN10TZPH043 CATEGORY: Pharmaceuticals GEOGRAPHY: Tanzania AUTHOR: Dr. Vishwa Modhia

Buy Now

Tanzania Radiotherapy Market Analysis Summary

By 2030, it is anticipated that the Tanzania Radiotherapy Market will reach a value of $xx Mn from $xx Mn in 2022, growing at a CAGR of xx% during 2022-30.

Tanzania is a low-income, developing country in East Africa bordering the Indian Ocean. Cancer is Tanzania's biggest noncommunicable disease, followed by diabetes and cardiovascular disease. Cancer cases have been continuously increasing in Tanzania. According to the International Agency for Research on Cancer (IARC), 42,060 new cancer cases are identified in Tanzania each year, with a high mortality rate of 28,610 deaths per year, indicating that many patients are diagnosed at advanced stages. Tanzanian patients have access to the four pillars of cancer care: prevention and education, early detection and diagnosis, treatment, and palliative care. Through prevention education programs, early detection and diagnosis, treatment, and palliative care, the Foundation for Cancer Care in Tanzania improves cancer care to improve the lives of Tanzanians.

Tanzania's most common cancers include cervical cancer, prostate cancer, and breast cancer. Tanzania's government spent 3.8% of its GDP on healthcare in 2020.

Tanzania Radiotherapy Market Analysis

Market Dynamics

Market Growth Drivers Analysis

Recognizing that the high cost of chemotherapy and radiotherapy is a source of financial hardship and catastrophic spending for low-income populations, the Tanzanian government has exempted cancer patients from paying for treatment since charging (cost sharing) was introduced into the public health sector in 1993. These aspects could boost Tanzania's, Radiotherapy Market.

Market restrains.

Patients in Tanzania have long wait times as a result of common LINAC problems. Tanzania suffers from a lack of infrastructure. For a Tanzanian population of 47.4 Mn, there are only 3 radiation centres, 2 radiation machines, and 2 brachytherapy machines, but they should have 313 radiation machines to treat their population. The majority of the country lacks access to cancer treatment. Due to economic and resource constraints that make it impossible to access frequently costly hands-on courses, radiation oncologists in low- and middle-income countries get mostly theoretical training. In Tanzania, radiation oncologists contour using paper and a needle, which is far less exact than the 3D approach. These factors may deter new entrants into the Tanzania Radiotherapy Market.

Competitive Landscape

Key Players

Varian Medical Systems - Varian Medical Systems is a company that provides radiation therapy equipment such as linear accelerators and brachytherapy systems to healthcare facilities around the world, including in Tanzania
Siemens Healthineers - Siemens is a German company that provides a range of medical equipment, including radiation therapy equipment such as linear accelerators and CT simulators
Accuray - Accuray is a US-based company that provides radiation therapy equipment such as the CyberKnife System, which uses precision radiation to treat cancerous and non-cancerous tumours
Elekta- Elekta is a company that provides radiation therapy equipment such as proton therapy systems and cyclotrons for the production of medical isotopes
The Ocean Road Cancer Institute (ORCI) in Dar es Salaam is the main centre for cancer treatment in Tanzania and offers radiotherapy services using advanced equipment

Healthcare Policies and Reimbursement Scenarios

In Tanzania, radiotherapy is regulated by the Tanzania Atomic Energy Commission (TAEC), which is the national regulatory body responsible for ensuring the safe and secure use of atomic energy in Tanzania. The TAEC is responsible for regulating the use of radiation in medicine, industry, research, and other areas to ensure that radiation exposure is within safe limits. Radiotherapy is partially reimbursed by the Tanzanian National Health Insurance Fund (NHIF), which provides health insurance coverage to eligible citizens.

1. Executive Summary
1.1 Disease Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Patient Journey
1.6 Health Insurance Coverage in Country
1.7 Active Pharmaceutical Ingredient (API)
1.8 Recent Developments in the Country

2. Market Size and Forecasting
2.1 Epidemiology of Disease
2.2 Market Size (With Excel & Methodology)
2.3 Market Segmentation (Check all Segments in Segmentation Section)

3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints

4. Competitive Landscape
4.1 Major Market Share

4.2 Key Company Profile (Check all Companies in the Summary Section)

4.2.1 Company
4.2.1.1 Overview
4.2.1.2 Product Applications and Services
4.2.1.3 Recent Developments
4.2.1.4 Partnerships Ecosystem
4.2.1.5 Financials (Based on Availability)

5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Diagnosis
5.3 Reimbursement Process for Treatment

6. Methodology and Scope

Radiotherapy Segmentation

By Type (Revenue, USD Billion):

External Beam Radiation Therapy
Linear Accelerators
Compact Advanced Radiotherapy Systems
Cyberknife
Gamma Knife
?Tomotherapy
Proton Therapy
Cyclotron
?Synchrotron
Internal Beam Radiation Therapy
Brachytherapy
Seeds
Applicators and Afterloaders
Electronic Brachytherapy
Systemic Radiation Therapy
?Others

?By Technology (Revenue, USD Billion):

External Beam Radiotherapy
Intensity-Modulated Radiation Therapy (IMRT)
Image-Guided Radiation Therapy (IGRT)
Stereotactic Radiation Therapy (SRT)
3D Conformal Radiation Therapy (3D-CRT)
Particle Therapy
Internal Beam Radiotherapy
Brachytherapy
High-Dose Rate Brachytherapy
Low-Dose Rate Brachytherapy
Image-Guided Brachytherapy
Pulse-Dose Rate Brachytherapy
Systemic Radiation Therapy
Intravenous Radiotherapy
Oral Radiotherapy?

By Application (Revenue, USD Billion):

Breast Cancer
Cervical Cancer
Colon and rectum Cancers
Stomach Cancer
Lung Cancer
Prostate Cancer
Skin Cancer
Liver Cancer
Other types of cancer

By End User (Revenue, USD Billion):

Hospitals
Radiotherapy Centers & Ambulatory Surgery Centers
?Cancer Research Institutes

Methodology for Database Creation

Our database offers a comprehensive list of healthcare centers, meticulously curated to provide detailed information on a wide range of specialties and services. It includes top-tier hospitals, clinics, and diagnostic facilities across 30 countries and 24 specialties, ensuring users can find the healthcare services they need.

Additionally, we provide a comprehensive list of Key Opinion Leaders (KOLs) based on your requirements. Our curated list captures various crucial aspects of the KOLs, offering more than just general information. Whether you're looking to boost brand awareness, drive engagement, or launch a new product, our extensive list of KOLs ensures you have the right experts by your side. Covering 30 countries and 36 specialties, our database guarantees access to the best KOLs in the healthcare industry, supporting strategic decisions and enhancing your initiatives.

How Do We Get It?

Our database is created and maintained through a combination of secondary and primary research methodologies.

1. Secondary Research

With many years of experience in the healthcare field, we have our own rich proprietary data from various past projects. This historical data serves as the foundation for our database. Our continuous process of gathering data involves:

Analyzing historical proprietary data collected from multiple projects.
Regularly updating our existing data sets with new findings and trends.
Ensuring data consistency and accuracy through rigorous validation processes.

With extensive experience in the field, we have developed a proprietary GenAI-based technology that is uniquely tailored to our organization. This advanced technology enables us to scan a wide array of relevant information sources across the internet. Our data-gathering process includes:

Searching through academic conferences, published research, citations, and social media platforms
Collecting and compiling diverse data to build a comprehensive and detailed database
Continuously updating our database with new information to ensure its relevance and accuracy

2. Primary Research

To complement and validate our secondary data, we engage in primary research through local tie-ups and partnerships. This process involves:

Collaborating with local healthcare providers, hospitals, and clinics to gather real-time data.
Conducting surveys, interviews, and field studies to collect fresh data directly from the source.
Continuously refreshing our database to ensure that the information remains current and reliable.
Validating secondary data through cross-referencing with primary data to ensure accuracy and relevance.

Combining Secondary and Primary Research

By integrating both secondary and primary research methodologies, we ensure that our database is comprehensive, accurate, and up-to-date. The combined process involves:

Merging historical data from secondary research with real-time data from primary research.
Conducting thorough data validation and cleansing to remove inconsistencies and errors.
Organizing data into a structured format that is easily accessible and usable for various applications.
Continuously monitoring and updating the database to reflect the latest developments and trends in the healthcare field.

Through this meticulous process, we create a final database tailored to each region and domain within the healthcare industry. This approach ensures that our clients receive reliable and relevant data, empowering them to make informed decisions and drive innovation in their respective fields.